UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000031894 |
|---|---|
| Receipt number | R000036404 |
| Scientific Title | Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis |
| Date of disclosure of the study information | 2018/04/01 |
| Last modified on | 2018/12/07 06:44:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis
Acronym
Cumulative network-meta-analyses, practice guidelines and real-world prescription
Scientific Title
Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis
Scientific Title:Acronym
Cumulative network-meta-analyses, practice guidelines and real-world prescription
Region
| Japan | North America | Europe |
Condition
Condition
post-menopausal osteoporosis
Classification by specialty
| Medicine in general | Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aims to compare the results of cumulative NMAs with the recommendations in post-menopausal osteoporosis practice guidelines, and with the actual prescription practices.
Basic objectives2
Others
Basic objectives -Others
not applicable
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Ranking of drugs to treat post-menopausal osteoporosis by means of cumulative network meta-analysis. Ranking of recommended post-menopausal osteoporosis in clinical practice guidelines in America. Ranking of actual prescriptions based on MEPS.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 50 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
post-menopausal osteoporois
Key exclusion criteria
Rheumatoid arthritis and related disease
Chronic renal failure
Cancer
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Toshi A Furukawa |
Organization
Kyoto University Graduate School of Medicine
Division name
Department of Health Promotion and Human Behavior, School of Public Health
Zip code
Address
Floor 2, G Buiding, Kyoto University Graduate School of Medicine, Yoshida Konoe-cho, Sakyo-ku, Kyoto, JAPAN
TEL
+81-75-753-9491
furukawa@kuhp.kyoto-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yuki Kataoka |
Organization
Hyogo Prefectural Amagasaki General Medical Center
Division name
Hospital Care Research Unit
Zip code
Address
2-17-77 Higashi-Naniwa-Cho, Amagasaki, Hyogo 660-8550, Japan
TEL
+81664807000
Homepage URL
youkiti@gmail.com
Sponsor or person
Institute
Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
JSPS Grant-in-Aid for Scientific Research (Grant Number17k19808)
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
https://bmjopen.bmj.com/content/8/12/e023218
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2018 | Year | 12 | Month | 03 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 12 | Month | 03 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2020 | Year | 03 | Month | 31 | Day |
Other
Other related information
It is an epi-epidemiologic research based on cumulative network meta-analysis and open data.
Management information
Registered date
| 2018 | Year | 03 | Month | 26 | Day |
Last modified on
| 2018 | Year | 12 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036404
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
